Cortex – Life Sciences Insights

30 Jan, 2023

Swedish government proposes fines between SEK 25k - 100m (approx. EUR 2,500 – 10 million) for late backorders by pharmaceutical companies

By Fredrika Allard

The Swedish government has on 24 January 2023 proposed a bill with actions aimed at improving the availability of medicines. The bill...

23 Jan, 2023

By Andrzej Balicki, Ph.D. Jolanta Dabrowicz

We would like to invite you to read our report summarising the second edition of the DLA Piper survey "Pharmaceutical and medical sector...

19 Jan, 2023

By Bruna Rocha Juliana Marcondes Victoria Cristofaro

During the World Economic Forum 2023 in Davos, specialists discussing the topic of health unanimously indicated that “the past three...

18 Jan, 2023

By Melissa Gilmore

On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023 into law, which contains the Food and Drug Omnibus...

12 Jan, 2023

By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski +1 more...

Download a copy of our December monthly briefing, which covers key updates and insights in the following areas: Clinical trials;...

11 Jan, 2023

By Emma Moran Suzanne Trounson

The New Zealand government has introduced the Therapeutic Products Bill which is intended to replace the existing medicines, medical...

10 Jan, 2023

By Melissa Gilmore

The FDA has denied two citizen petitions filed on behalf of the Informed Consent Action Network (ICAN) requesting the agency revoke its...

06 Jan, 2023

By Kirsten Axelsen

The American Enterprise Institute (AEI), a public policy think tank, published a piece this week by Kirsten Axelsen on the potential cost...

03 Jan, 2023

By Mariana Ricardo

APIFARMA – Portuguese Pharmaceutical Industry Association (Apifarma) recently approved a revision to the Code of Ethics for Promotion...